These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31016228)

  • 1. Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells.
    Wang L; Ning J; Wakimoto H; Wu S; Wu CL; Humphrey MR; Rabkin SD; Martuza RL
    Mol Ther Oncolytics; 2019 Jun; 13():58-66. PubMed ID: 31016228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
    Kanai R; Wakimoto H; Martuza RL; Rabkin SD
    Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic herpes simplex virus vector g47delta in combination with androgen ablation for the treatment of human prostate adenocarcinoma.
    Fukuhara H; Martuza RL; Rabkin SD; Ito Y; Todo T
    Clin Cancer Res; 2005 Nov; 11(21):7886-90. PubMed ID: 16278413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
    J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells.
    Wang L; Zi H; Luo Y; Liu T; Zheng H; Xie C; Wang X; Huang X
    Stem Cell Res Ther; 2020 Jun; 11(1):258. PubMed ID: 32586404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
    Zeng WG; Li JJ; Hu P; Lei L; Wang JN; Liu RB
    Oncol Rep; 2013 Jun; 29(6):2355-61. PubMed ID: 23525624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.
    Yan J; Tang D
    Exp Cell Res; 2014 Oct; 328(1):132-142. PubMed ID: 25149681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of breast cancer stem cells with oncolytic herpes simplex virus.
    Li J; Zeng W; Huang Y; Zhang Q; Hu P; Rabkin SD; Liu R
    Cancer Gene Ther; 2012 Oct; 19(10):707-14. PubMed ID: 22898897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
    Passer BJ; Castelo-Branco P; Buhrman JS; Varghese S; Rabkin SD; Martuza RL
    Cancer Gene Ther; 2009 Jul; 16(7):551-60. PubMed ID: 19197321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of human thyroid carcinoma cells with the g47delta oncolytic herpes simplex virus.
    Wang JN; Xu LH; Zeng WG; Hu P; Rabkin SD; Liu RR
    Asian Pac J Cancer Prev; 2015; 16(3):1241-5. PubMed ID: 25735362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
    Duebgen M; Martinez-Quintanilla J; Tamura K; Hingtgen S; Redjal N; Wakimoto H; Shah K
    J Natl Cancer Inst; 2014 Jun; 106(6):dju090. PubMed ID: 24838834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells.
    Hu Y; Guo R; Wei J; Zhou Y; Ji W; Liu J; Zhi X; Zhang J
    Cell Death Dis; 2015 Dec; 6(12):e2020. PubMed ID: 26673665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
    Rybak AP; He L; Kapoor A; Cutz JC; Tang D
    Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo.
    Ying C; Xiao BD; Qin Y; Wang BR; Liu XY; Wang RW; Fang L; Yan H; Zhou XM; Wang YG
    Acta Pharmacol Sin; 2018 Mar; 39(3):405-414. PubMed ID: 28880012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
    Varghese S; Rabkin SD; Liu R; Nielsen PG; Ipe T; Martuza RL
    Cancer Gene Ther; 2006 Mar; 13(3):253-65. PubMed ID: 16179929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo.
    Yu F; Zhao J; Hu Y; Zhou Y; Guo R; Bai J; Zhang S; Zhang H; Zhang J
    Oncol Rep; 2016 Jul; 36(1):356-64. PubMed ID: 27175939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J; Hu P; Zeng M; Rabkin SD; Liu R
    Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.